BridgeMD
New treatment option for Obesity Type 2 Diabetes Mellitus
Official title Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy
ClinicalTrials.gov ID: NCT07518407
What this study is testing
- What it's testing
- This pilot study will evaluate the feasibility, acceptability, and perceived usefulness of the SWITCH mobile nutrition behavioral intervention among adults receiving GLP-1 receptor agonist therapy for obesity and/or type 2 diabetes. Participants will complete baseline assessments, receive a 6-week app-based nutrition intervention consisting of daily dietary self-monitoring and weekly learning modules, and complete follow-up assessments and a structured interview.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65 years.
- BMI between 30 - 49.9 kg/m2 and/or diagnosed with type 2 diabetes.
- Currently prescribed and using GLP-1 receptor therapy for at least 4 weeks.
- Own a smartphone (Android or iOS) with an active data plan to support app-based intervention delivery.
- Residing anywhere in the United States.
You likely can't join if
- Presence of type 1 diabetes mellitus
- Severe complications, including but not limited to proliferative retinopathy, severe peripheral neuropathy, nephropathy requiring dialysis, active...
- Current or recent (within 6 months) participation in another structured weight loss program or clinical trial that may interfere with study outcomes.
- Pregnancy, breastfeeding, or plans to become pregnant during the study period.
- Current use of another investigational weight loss device or medication.
- Diagnosed eating disorders (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder) or other psychiatric conditions that may affect adherence...
See the full eligibility criteria
- Age between 18 and 65 years.
- BMI between 30 - 49.9 kg/m2 and/or diagnosed with type 2 diabetes.
- Currently prescribed and using GLP-1 receptor therapy for at least 4 weeks.
- Own a smartphone (Android or iOS) with an active data plan to support app-based intervention delivery.
- Residing anywhere in the United States.
- Must be willing and able to reduce caloric intake.
- Be free of major health or psychiatric diseases, drug, or alcohol dependency.
- Willing to sign informed consent.
- Presence of type 1 diabetes mellitus
- Severe complications, including but not limited to proliferative retinopathy, severe peripheral neuropathy, nephropathy requiring dialysis, active foot ulcers, or recent hospitalization for diabetic ketoacidosis or...
- Current or recent (within 6 months) participation in another structured weight loss program or clinical trial that may interfere with study outcomes.
- Pregnancy, breastfeeding, or plans to become pregnant during the study period.
- Current use of another investigational weight loss device or medication.
- Diagnosed eating disorders (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder) or other psychiatric conditions that may affect adherence to behavioral interventions, as determined by study staff.
- Severe cardiovascular, hepatic, renal, or pulmonary disease that would limit participation in moderate physical activity or dietary modification.
- Active cancer treatment (chemotherapy, radiation, or surgery) within the past 12 months.
- Substance use disorder or alcohol dependency within the past 12 months.
- Cognitive impairment or any medical or mental condition that would interfere with the ability to understand or comply with study procedures.
- Lack of reliable internet or smartphone access, or unwillingness to use a mobile app for tracking and communication.
The study team makes the final eligibility decision.
Where it's taking place
- Columbia, South Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Columbia, South Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.